# Efficacy and Safety of LAIS® Mites Sublingual Tablets

> **NCT02277483** · PHASE4 · UNKNOWN · sponsor: **Ajou University School of Medicine** · enrollment: 45 (estimated)

## Conditions studied

- Allergic Conditions

## Interventions

- **DRUG:** LAIS®

## Key facts

- **NCT ID:** NCT02277483
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2015-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02277483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02277483, "Efficacy and Safety of LAIS® Mites Sublingual Tablets". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02277483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*